PDF) Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: A systematic literature review
PDF) Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study
PDF) Study on the conditions applicable to contracts relating to intellectual property in the European Union
V Registru evidentiran nov nosilec - KUD Beltinci | Nesnovna kulturna dediščina Slovenije
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
Etna stavba lodí oběť sportovní vložky do bot do conversek arabština Velké množství Koště
Volume 2, Issue 1
Volume 2, Issue 1
(PDF) Breast Cancer Susceptibility—Towards Individualised Risk Prediction
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
PDF) Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk
Fotogaléria - Rok 2023 • Marjanka
Marjanka Rebula in njeno delo » Noviglas
PDF) Exceptions to the rule of informed consent for research with an intervention
Fotogaléria - Rok 2023 • Marjanka
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology
The 2020 Annual Meeting of the International Genetic Epidemiology Society
Na Marjánce | Taneční sál
omicsGAT: Graph Attention Network for Cancer Subtype Analyses
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
omicsGAT: Graph Attention Network for Cancer Subtype Analyses
Praha 6 chce opět spravovat polikliniku Marjánka - NašePraha.cz
PDF) Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C , RAD51D , BARD1 updates to tumour pathology and cancer incidence
PDF) Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1 -like status, tumor-infiltrating immune cells and survival